Inventor · disambiguated record
Gary Cook
Also filed as: COOK GARY · COOK GARY P · COOK GARY PAUL
12 granted patents·11 pending applications·56 citations·filing 2004–2023
88Inventor score
Files withKALVISTA PHARMACEUTICALS LTD4COOK GARY P3CALIAS PERICLES2CHENG XIAOQIN2EYEGATE PHARMACEUTICALS INC2
Top patents by PatentIndex Score
23 records- 0192US8088754B2Anti-proliferative compounds, compositions, and methods of use thereofCHENG XIAOQIN·Filed 2009·Granted Jan 3, 2012·27 cites·6 claims
- 0285US8268802B2Anti-proliferative compounds, compositions, and methods of use thereofCHENG XIAOQIN·Filed 2009·Granted Sep 18, 2012·6 cites·4 claims
- 0383US7553825B2Anti-proliferative compounds, compositions, and methods of use thereofGILEAD SCIENCES INC·Filed 2004·Granted Jun 30, 2009·13 cites·9 claims
- 0480US9149525B2Delivery of corticosteroids through iontophoresisJAFFE MIKE·Filed 2013·Granted Oct 6, 2015·2 cites·7 claims
- 0579US10376463B2Ocular iontophoretic delivery of dexamethasone and formulations thereofJAFFE MIKE·Filed 2012·Granted Aug 13, 2019·5 cites·1 claims
- 0676US11234939B2Dosage forms comprising a plasma kallikrein inhibitorKALVISTA PHARMACEUTICALS LTD·Filed 2018·Granted Feb 1, 2022·1 cites·53 claims
- 0764US8900636B2Controlled release compositionsCOOK GARY P·Filed 2004·Granted Dec 2, 2014·1 cites·13 claims
- 0864US8871269B2Method for the preparation of controlled release formulationsCOOK GARY P·Filed 2004·Granted Oct 28, 2014·1 cites·38 claims
- 0962US2015079179A1Sustained release formulations of peptidomimetic drugs and uses thereofJERINI OPHTHALMIC INC·Filed 2014·Application pending·0 cites
- 1061US2009306579A1Delivery of corticosteroids through iontophoresisEYEGATE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1160US9820935B2Delivery of corticosteroids through iontophoresisEYEGATE PHARMACEUTICALS INC·Filed 2016·Granted Nov 21, 2017·0 cites·7 claims
- 1258US2015037429A1Controlled Release MicroparticlesVALEANT PHARMACEUTICALS INT·Filed 2014·Application pending·0 cites
- 1357US2006030545A1Anti-proliferative compounds, compositions, and methods of use thereofGILEAD SCIENCES INC·Filed 2005·Application pending·0 cites
- 1457US2025375467A1Sustained release silica hydrogel composites for treating ophthalmological conditions and methods of using sameASTELLAS US LLC·Filed 2023·Application pending·0 cites
- 1550US9849100B2Pharmaceutical compositions suitable for parenteral administration comprising aqueous suspensions of benzylamine derivatives having low solubilitiesKALVISTA PHARMACEUTICALS LTD·Filed 2014·Granted Dec 26, 2017·0 cites·35 claims
- 1647US10478409B2Pharmaceutical compositionsKALVISTA PHARMACEUTICALS LTD·Filed 2017·Granted Nov 19, 2019·0 cites·32 claims
- 1747US2012244192A1Sustained release formulations of peptidomimetic drugs and uses thereofCOOK GARY P·Filed 2010·Application pending·0 cites
- 1846US2020261383A1Pharmaceutical compositionsKALVISTA PHARMACEUTICALS LTD·Filed 2018·Application pending·0 cites
- 1943US8877229B2Controlled release microparticlesCAMPBELL KATHLEEN M·Filed 2006·Granted Nov 4, 2014·0 cites·39 claims
- 2042US2005260153A1Facilitation of iontophoresis using charged moietiesCALIAS PERICLES·Filed 2005·Application pending·0 cites
- 2142US2005260651A1Enhanced biologically active conjugatesCALIAS PERICLES·Filed 2005·Application pending·0 cites
- 2237US2018250313A1Compounds and formulations for treating ophthalmic diseasesVIEWPOINT THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2334US2010143485A1Oxycontin controlled release formulations and methods of using sameHUDNUT PAUL S·Filed 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →